Detection of high-risk Human Papillomavirus in prostate cancer from a UK based population

[1]  Z. Piravi-Vanak,et al.  A global systematic review and meta-analysis on prevalence of the aflatoxin B1 contamination in olive oil , 2022, Journal of Food Science and Technology.

[2]  J. Lawson,et al.  Evidence for a causal role by human papillomaviruses in prostate cancer – a systematic review , 2020, Infectious Agents and Cancer.

[3]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[4]  S. Uddin,et al.  Prevalence and Type Distribution of High-Risk Human Papillomavirus (HPV) in Breast Cancer: A Qatar Based Study , 2020, Cancers.

[5]  C. Fotopoulou,et al.  HPV vaccination and cancer prevention. , 2020, Best practice & research. Clinical obstetrics & gynaecology.

[6]  M. Moghoofei,et al.  Association between human papillomavirus infection and prostate cancer: A global systematic review and meta‐analysis , 2019, Asia-Pacific journal of clinical oncology.

[7]  G. Morgia,et al.  High rate of detection of ultrasound signs of prostatitis in patients with HPV-DNA persistence on semen: role of ultrasound in HPV-related male accessory gland infection , 2019, Journal of Endocrinological Investigation.

[8]  R. Ocadiz-Delgado,et al.  Association between HPV infection and prostate cancer in a Mexican population , 2018, Genetics and molecular biology.

[9]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[10]  E. Montomoli,et al.  Epidemiology and prevention of Human Papillomavirus. , 2018, Annali di igiene : medicina preventiva e di comunita.

[11]  Richard J. Edwards,et al.  High risk human papilloma viruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer , 2017, Infectious Agents and Cancer.

[12]  Zhihua Tao,et al.  Association between human papillomavirus and prostate cancer: A meta-analysis. , 2017, Oncology letters.

[13]  D. Perumal,et al.  Association of High Risk Human Papillomavirus and Breast cancer: A UK based Study , 2017, Scientific Reports.

[14]  M. I. Rodriguez,et al.  Human Papilloma Virus Detection by INNOLiPA HPV in Prostate Tissue from Men of Northeast Mexico , 2016, Asian Pacific Journal of Cancer Prevention : APJCP.

[15]  G. H. Ashrafi,et al.  Pathogenesis of Human Papillomavirus – Immunological Responses to HPV Infection , 2016 .

[16]  S. Beddows,et al.  Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study , 2016, BMJ Open.

[17]  Zhibin Hu,et al.  Worldwide Prevalence of Human Papillomavirus and Relative Risk of Prostate Cancer: A Meta-analysis , 2015, Scientific Reports.

[18]  W. Delprado,et al.  Early Human Papilloma Virus (HPV) Oncogenic Influences in Breast Cancer , 2015, Breast cancer : basic and clinical research.

[19]  G. Nesi,et al.  Human papillomavirus infection is not related with prostatitis-related symptoms: results from a case-control study. , 2014, International braz j urol : official journal of the Brazilian Society of Urology.

[20]  R. Tachezy,et al.  HPV persistence and its oncogenic role in prostate tumors , 2012, Journal of medical virology.

[21]  J. Simpson,et al.  Myocardial Infarction and Risk of Suicide: A Population-Based Case-Control Study , 2010, Circulation.

[22]  I. Thompson,et al.  Human Papillomavirus Types 16, 18, and 31 Serostatus and Prostate Cancer Risk in the Prostate Cancer Prevention Trial , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[23]  F. Schmidt.  Meta-Analysis , 2008 .

[24]  Jianfeng Xu,et al.  Inflammation in prostate carcinogenesis , 2007, Nature Reviews Cancer.

[25]  P. Doyle,et al.  Results from a Case-Control Study of Risk Factors for Congenital Heart Defects in Saudi Arabian Infants , 2006 .

[26]  B. Wells,et al.  Prostate cancer and sexually transmitted diseases: a meta-analysis. , 2005, Family medicine.

[27]  Ian M Thompson,et al.  Mechanisms of Disease: prostate cancer—a model for cancer chemoprevention in clinical practice , 2005, Nature Clinical Practice Oncology.

[28]  H. Adami,et al.  Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  U. Gyllensten,et al.  Real-Time PCR-Based System for Simultaneous Quantification of Human Papillomavirus Types Associated with High Risk of Cervical Cancer , 2003, Journal of Clinical Microbiology.

[30]  C J L M Meijer,et al.  The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.

[31]  L. Dennis,et al.  Meta-Analysis of Measures of Sexual Activity and Prostate Cancer , 2002, Epidemiology.

[32]  A. Basarab,et al.  Detection of Cervical Infections in Colposcopy Clinic Patients , 2001, Journal of Clinical Microbiology.

[33]  J. Stanford,et al.  Sexual factors and the risk of prostate cancer. , 2001, American journal of epidemiology.

[34]  R. Hayes,et al.  Sexual behaviour, STDs and risks for prostate cancer , 2000, British Journal of Cancer.

[35]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[36]  M. Lehtinen,et al.  Sero‐epidemiologal association between human‐papillomavirus infection and risk of prostate cancer , 1998 .

[37]  K. Pienta,et al.  Risk Factors for Prostate Cancer , 1993, Annals of Internal Medicine.

[38]  A. Ravich,et al.  Prophylaxis of cancer of the prostate, penis, and cervix by circumcision. , 1951, New York state journal of medicine.

[39]  J. Pipas,et al.  Viral sequences in human cancer. , 2018, Virology.

[40]  M. Kara,et al.  Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in turkish men with prostate cancer , 2017, International braz j urol : official journal of the Brazilian Society of Urology.

[41]  M. Laufer,et al.  Human Papillomavirus (HPV), HPV-Related Disease, and the HPV Vaccine. , 2008, Reviews in obstetrics & gynecology.

[42]  Soon-Cheang Quah,et al.  A Current Perspective , 2007 .

[43]  M. Lehtinen,et al.  Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. , 1998, International journal of cancer.

[44]  L. Kolonel,et al.  Prostate cancer: a current perspective. , 1991, Epidemiologic reviews.

[45]  D. Miles..  Cancer of the prostate: the silent man-killer. , 1970, Delaware medical journal.